Beta

Proposal:Allergy Testing Access Act of 2021

This proposal is archived and closed to further debate. It was introduced in the 117th Congress, which has concluded, and the bill was not enacted into law.
Geographic Scope
National

Description

Allergy Testing Access Act of 2021

This bill requires equal coverage of two types of allergy tests under Medicaid and Medicare.

Specifically, in vitro specific IgE tests (blood tests) and percutaneous tests (skin tests) must be treated equally with respect to (1) medical necessity or other coverage requirements, (2) frequency limits, and (3) allergen unit limits.

Bill Title

Allergy Testing Access Act of 2021

Linked Goals

Steps

  • 2021-03-11: Read twice and referred to the Committee on Finance.
  • 2021-03-11: Introduced in Senate

Projected Outcome

A more informed proposal or public response aligned with the Promote General Welfare goal.